Abbott Determined To Improve Image Of HIV Tests After Regulatory Setbacks
This article was originally published in The Gray Sheet
Executive SummaryApplications submitted by African countries for Abbott's Determine rapid HIV diagnostic test will be evaluated by health care consulting firm Axios International at the end of April, Abbott said March 27.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.